SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-169247
Filing Date
2021-05-21
Accepted
2021-05-21 16:04:04
Documents
12
Period of Report
2021-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d132541d8k.htm   iXBRL 8-K 22660
  Complete submission text file 0001193125-21-169247.txt   155965

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgem-20210517.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20210517_lab.xml EX-101.LAB 20374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20210517_pre.xml EX-101.PRE 12771
5 EXTRACTED XBRL INSTANCE DOCUMENT d132541d8k_htm.xml XML 3718
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 21948963
SIC: 2836 Biological Products, (No Diagnostic Substances)